Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BUPROPION\NALTREXONE for Obesity: Side Effects & Safety Data

Lose Weight Fast — The 21-Day Smoothie Diet

36 fat-burning recipes + shopping lists. Results in the first week.

Get the Program

There are 726 adverse event reports in the FDA FAERS database where BUPROPION\NALTREXONE was used for Obesity.

Most Reported Side Effects for BUPROPION\NALTREXONE

Side Effect Reports % Deaths Hosp.
Nausea 1,857 23.9% 0 113
Headache 1,054 13.6% 0 69
Dizziness 986 12.7% 0 61
Vomiting 646 8.3% 0 64
Constipation 602 7.8% 0 30
Feeling abnormal 550 7.1% 0 35
Fatigue 474 6.1% 1 30
Anxiety 378 4.9% 0 28
Insomnia 367 4.7% 0 34
Diarrhoea 350 4.5% 0 28
Patient dissatisfaction with treatment 340 4.4% 0 9
Drug titration error 338 4.4% 0 44
Blood pressure increased 322 4.2% 0 36
Drug ineffective 313 4.0% 0 6
Tremor 306 3.9% 0 21

Other Indications for BUPROPION\NALTREXONE

Weight control (2,842) Product used for unknown indication (2,801) Overweight (803) Weight decreased (426) Decreased appetite (35) Depression (24) Weight increased (17) Food craving (13) Anxiety (9) Appetite disorder (9)

Other Drugs Used for Obesity

SEMAGLUTIDE (2,586) LIRAGLUTIDE (1,090) TIRZEPATIDE (700) ORLISTAT (163) PHENTERMINE (127) DULAGLUTIDE (109) METFORMIN (100) PHENTERMINE\TOPIRAMATE (86) TOPIRAMATE (86) LORCASERIN (79)

Related Pages

BUPROPION\NALTREXONE Full Profile All Obesity Drugs BUPROPION\NALTREXONE Demographics BUPROPION\NALTREXONE Timeline